Home › Dermatomyositis › Kansas › Kansas City
Dermatomyositis clinical trials in Kansas City, KS
3 studies for Dermatomyositis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University of Kansas Cancer Center, Kansas City
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecruitingPhase 2/3
- University of Kansas Medical Center - Accepting Adult Patients, Kansas City
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Kansas Medical Center, Kansas City
Dermatomyositis trials in other cities
- Durham, NC8 studies
- Washington, DC7 studies
- Boston, MA5 studies
- Houston, TX5 studies
- New York City, NY5 studies
- Pittsburgh, PA5 studies
- Miami, FL4 studies
- Philadelphia, PA4 studies
- Baltimore, MD4 studies
- Aurora, CO3 studies
- Jacksonville, FL3 studies
- Phoenix, AZ3 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Heart Failure13 studies
- Obesity13 studies
- Interstitial Lung Diseases13 studies
- Cystic Fibrosis13 studies
- Breast Cancer12 studies
- Bladder Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- COPD9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.